Make the inference visible before trusting it
When an outcome is undefined after death, the survivor average causal effect targets people who would survive under either treatment, but randomisation alone rarely identifies that latent comparison.
Quality of life, cognition or functional status cannot be measured after a participant dies because the outcome no longer exists. This is truncation by death, not ordinary missing data. Comparing observed survivors can break randomisation when treatment affects survival. The survivor average causal effect addresses a narrower question: what is the treatment effect among people who would survive under either assignment? The gold standard states that estimand clearly and shows the assumptions or bounds needed to learn about it.
Frame the claimROUTE 02 · CHAPTERS 4–6
Work the evidenceROUTE 03 · CHAPTERS 7–9
Test transferROUTE 04 · CHAPTERS 10–12
Audit and continue
Open the chapter contents · Visit the Experimental Design root
Chapter contents
01 · Frame the claim
02 · Work the evidence
03 · Test transfer
A missing outcome exists but was not recorded; an outcome truncated by death is undefined at the assessment time. Imputing a quality-of-life score for a person who died changes the outcome rather than recovering a missing value. Define survival time, the outcome time and any composite alternative before analysis. Death can still be analysed directly, but it cannot be ignored while conditioning the survivor outcome on observed availability.
2. Define potential survival and the always-survivor stratum
Let S(1) and S(0) indicate whether a person would survive under treatment and control. The always-survivor stratum contains people with S(1)=S(0)=1. The survivor average causal effect compares their potential survivor outcomes under both assignments. This is a principal-stratum estimand: membership is defined by two potential survival states, only one of which is observed. It is not simply the difference among people who happened to survive in each arm.
Contents · Previous chapter · Experimental Design root · Next chapter
3. See why observed-survivor comparisons are selected
If treatment improves survival, treated survivors include some people who would have died under control. Control survivors do not contain an equivalent group. Their outcome distributions can differ even when treatment has no direct effect on the survivor outcome. Baseline adjustment may reduce imbalance but does not generally reveal latent stratum membership. Draw the principal-strata table so the mixture problem is visible before fitting a regression.
| Observed group | Principal-stratum mixture | Risk |
|---|---|---|
| Treated survivors | Always survivors plus treatment-protected | Composition changed by treatment |
| Control survivors | Always survivors plus control-protected | Not the same mixture |
| Observed deaths | Remaining survival strata | Outcome undefined |
Contents · Previous chapter · Experimental Design root · Next chapter
4. Decide whether the estimand answers a useful question
The always-survivor effect is causally coherent, but the target group may not be identifiable before treatment. Decision-makers may also care about joint survival and quality, mortality itself or a ranked composite. Explain why the SACE is scientifically relevant and present survival risks alongside it. Avoid language suggesting a benefit “for survivors” generally; the effect concerns people who would survive under either treatment condition.
Contents · Previous chapter · Experimental Design root · Next chapter
5. State identification assumptions in ordinary language
Randomisation identifies marginal survival and observed outcome distributions, not the joint potential survival states or their stratum-specific outcomes. Point estimation often invokes monotonicity, which rules out treatment-caused deaths, plus assumptions about outcome distributions, covariates or latent associations. These assumptions are not guaranteed by the trial. Give a subject-matter reason for each and specify sensitivity analyses before examining the preferred result.
| Assumption | Meaning | Caution |
|---|---|---|
| Monotonicity | Treatment causes no deaths for any person | Stronger than average benefit |
| Outcome model | Links covariates and latent outcomes | Model dependence |
| Latent association | Connects unobserved survival type to outcome | Requires sensitivity range |
Contents · Previous chapter · Experimental Design root · Next chapter
6. Worked example: rehabilitation after critical illness
In an invented trial, 800 patients receive an early rehabilitation programme or usual care. Ninety-day survival is 82 percent versus 75 percent, and mean mobility among observed survivors is 64 versus 61. The three-point survivor difference is not automatically causal because treatment survivors include people who might not have survived under control. Investigators estimate a SACE under monotonicity and vary an unobserved rank-correlation parameter linking survival type to mobility. Estimates range from a one-point disadvantage to a four-point benefit, so the report foregrounds survival and the sensitivity range rather than one adjusted survivor mean.
Contents · Previous chapter · Experimental Design root · Next chapter
Nonparametric or assumption-assisted bounds can show what the randomised data permit without selecting one latent mixture. Monotonicity, stochastic dominance or baseline covariates may narrow bounds, but each restriction changes their meaning. Report the unrestricted or minimally restricted range where feasible, then show how additional assumptions sharpen it. A wide bound is useful evidence that the design cannot answer a precise SACE question on its own.
| Analysis output | What it communicates | Good practice |
|---|---|---|
| Minimal bound | What weak assumptions permit | Report before sharpening |
| Restricted bound | Effect of added science | Name each restriction |
| Point estimate | One model or identification set | Never present as design-only |
Contents · Previous chapter · Experimental Design root · Next chapter
8. Changed-context transfer check: cognitive outcome after surgery
Move from critical-care mobility to cognition one year after two surgical strategies. Treatment may improve survival while survivors differ in frailty and neurological risk. The SACE framework transfers, but monotonicity may be doubtful if surgery can both prevent and cause deaths for different people. Preoperative predictors can support stratified bounds without identifying individuals’ counterfactual survival. A composite such as alive with intact cognition answers a different, sometimes more actionable, question.
Contents · Previous chapter · Experimental Design root · Next chapter
Randomisation does not make observed survivors comparable. Monotonicity is not “no average harm”; it rules out an entire individual potential-survival type. A SACE does not describe people who survive only because of treatment, and it may not generalise to all randomised participants. Sensitivity parameters need substantive scales and ranges. Assigning death the worst numeric score creates a composite estimand rather than solving truncation invisibly.
Contents · Previous chapter · Experimental Design root · Next chapter
Publish survival and outcome time points, causes and timing of death, outcome definition, treatment assignment, missing outcomes among survivors and baseline covariates. Show the principal-strata mapping, observed mixtures, identification restrictions, bound formulas, code and sensitivity grid. Report convergence and finite-sample behaviour where modelling is complex. Keep ordinary missingness among survivors separate from truncation and address both in the analysis plan.
| Audit layer | Retain | Failure signal |
|---|---|---|
| Estimand | Survival and outcome times | Survivors vaguely defined |
| Mixtures | Principal-strata table | Observed survivors treated as random |
| Sensitivity | Ranges and code | One untestable value |
Contents · Previous chapter · Experimental Design root · Next chapter
Why not analyse survivors only? Treatment can change who survives. Is death just missing data? No; the survivor outcome is undefined after death. Who are always survivors? People who would survive under either treatment. Can we identify them individually? Usually not. Does monotonicity follow from better average survival? No. What if bounds are wide? That honestly shows limited identification and can motivate a different endpoint or design.
Contents · Previous chapter · Experimental Design root · Next chapter
12. The gold standard keeps survival inside the causal question
A credible survivor-effect analysis begins by admitting that death changes the existence of the outcome. It defines the always-survivor estimand, displays the selected mixtures in observed survivor groups and separates randomisation from untestable identification assumptions. Bounds and sensitivity analyses then reveal what the data support. The gold standard is not a single adjusted mean; it is a causal claim whose dependence on survival has been made impossible to miss.
Contents · Previous chapter · Experimental Design root · Return to Experimental Design
Continue through verified routes
Core route
- Experimental Design: subject root and specialist index
- The Gold Standard of Education: learning transfers into life
- The Gold Standard: eduKate Singapore
- How X Works: systems and first-principles hub
Specialist route
- Principal stratification, post-randomisation events and estimand interpretation
- Missing outcomes, intercurrent events and estimand alignment
- Treatment fidelity, protocol deviations and the effect being estimated
- Pragmatic trials, treatment variation and usual-care drift
- Noncompliance, instrumental variables and complier effects
